Comparative tolerability of therapies for ulcerative colitis.

@article{Ardizzone2002ComparativeTO,
  title={Comparative tolerability of therapies for ulcerative colitis.},
  author={Sandro Ardizzone and Gabriele Bianchi Porro},
  journal={Drug safety},
  year={2002},
  volume={25 8},
  pages={
          561-82
        }
}
This article reviews the clinical pharmacology, adverse events, and comparative tolerability of the drugs commonly available for treating ulcerative colitis. Synthetic glucocorticoids are the most commonly used conventional corticosteroids in the treatment of ulcerative colitis. Corticosteroids can be expected to impact on every organ system and most metabolic activities of the body. Suppression of the hypothalamic-pituitary-adrenal axis is common, but reversible, with conventional… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

The diagnosis and management of acute and chronic urticaria: 2014 update.

The Journal of allergy and clinical immunology • 2014
View 1 Excerpt

Beclomethasone dipropionate in Crohn's ileitis: a randomised, double-blind trial.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver • 2011
View 1 Excerpt

Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society • 2011

Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2010
View 1 Excerpt

Drug Insight: aminosalicylates for the treatment of IBD

Nature Clinical Practice Gastroenterology &Hepatology • 2007

Similar Papers

Loading similar papers…